Open AccessComment on "Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors"
Author(s) -
S.-H. Kim,
D.-W. Kim
Publication year - 2015
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2014.123232
Subject(s) - myeloid leukemia , medicine , tyrosine kinase , tyrosine kinase inhibitor , cancer research , cancer , receptor